Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 0.31. At the close of
During the last session, Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares were 0.83 million, with the beta value of the company hitting 0.42. At the end
During the last session, Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares were 0.75 million, with the beta value of the company hitting 0.43. The 52-week high
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne